← Back to All Filings

Cigna CEO David Cordani Purchases ~$1M in Company Stock (CI)

Low SignificanceNovember 3, 2025 at 3:01:59 PM EST

Cigna Group

$CI4CIK: 0001739940

Subscribe to track CI

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Cigna CEO Purchases ~$1M in Company Stock (CI)

Company: Cigna Group (CI) Form: 4 | Filed: 2025-11-03 Significance: Low

Insider: Cordani David Title: Chairman & CEO | Relationship: Director, Officer

Transaction: • Type: Purchase • Shares: 4,134 • Price: $241.88 • Value: $999,863 • Owned After: 621,872 (total direct & indirect)

Key Insight: The Chairman & CEO made a ~$1M purchase. While a large sum, it represents a negligible fraction (0.0015%) of the company's $66B market cap, classifying it as a low-significance transaction.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Cigna Group (CI)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chairman & CEO, David Cordani, purchased approximately $1 million worth of Cigna stock through a trust.
  • Market Impact: The transaction is considered routine and is unlikely to have a material impact on the stock price due to its small size relative to the company's market capitalization.

Company Information

FieldValue
CompanyCigna Group
Ticker SymbolCI
CIK0001739940
IndustryHospital & Medical Service Plans

Insider Information

FieldValue
NameCordani David
CIK0001318751
Title/PositionChairman & CEO
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-03
Transaction CodeP (Purchase)
Security TypeCommon Stock, $.01 Par Value
Shares Involved4,134
Price Per Share$241.8762
Total Value$999,863.05
Shares Owned After157,935 (in this specific trust)
Ownership TypeIndirect (By Trust)

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$999,863.05
% of Market Cap0.0015%
Shares Transacted4,134
% of Shares Outstanding0.0015%
Post-Transaction Ownership (Total)621,872 shares (0.23% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap company with a market capitalization of approximately $66 billion, a $1 million transaction is financially immaterial.
  • Ownership Concentration: The purchase slightly increases the CEO's total holdings to 0.23% of all outstanding shares, which is not a significant concentration.
  • Transaction Significance: The transaction's value is less than 0.1% of the market cap and the shares involved are less than 0.1% of shares outstanding, firmly placing this in the 'Low' significance category.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is too small relative to Cigna's market capitalization and public float to influence investor sentiment or stock price in a meaningful way.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The trade size is a tiny fraction of the stock's typical daily trading volume.
  • Sentiment Indicator: Neutral. While an insider purchase is technically a positive signal, its immaterial size in this context renders it neutral.

Additional Context

Transaction Notes

  • Special Circumstances: The purchase was made indirectly through a trust. The filing also notes other holdings in a GRAT and 401(k), indicating a structured approach to asset management. Footnote 1 indicates the shares were bought in a price range from $241.876 to $241.97.
Topics:#SECFiling#InsiderTrading#Cigna#CI#Form4#InsiderBuy#StockMarket#Investing#Healthcare

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.